Articles from Sibannac, Inc.

Sibannac's CEO, David Mersky to exchange 31,666,667 common shares for 263,889 shares of Series D Convertible Preferred Stock, reducing Sibannac's common shares outstanding by about 21%

Sibannac's Apollo Wellness Centers Joint Venture Releases Primer Video Showing the Doc-Rx Platform Behind Its Planned Clinic Network

Sibannac Takes Majority Stake in Apollo Wellness Centers, a New Joint Venture with Doc-RxSibannac now owns 51% of Apollo, which launches on Doc-Rx's operating telehealth and U.S.-made peptide platform and plans to stand up wellness clinics through a licensing model

Special Purpose Vehicle to Be Formed in Connection With Proposed Transaction